Production (Stage)
MediciNova, Inc.
MNOV
$1.41
$0.01991.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -100.00% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -100.00% | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -100.00% | -- | -- |
| SG&A Expenses | 7.42% | 4.54% | -10.29% | -13.42% | -9.93% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.07% | 16.29% | 2.92% | -19.21% | -21.92% |
| Operating Income | -26.49% | -28.03% | -12.60% | 26.68% | 28.97% |
| Income Before Tax | -32.70% | -28.89% | -8.20% | 34.39% | 38.18% |
| Income Tax Expenses | 83.33% | 83.33% | 7.14% | 7.14% | 7.14% |
| Earnings from Continuing Operations | -32.71% | -28.91% | -8.20% | 34.38% | 38.17% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -32.71% | -28.91% | -8.20% | 34.38% | 38.17% |
| EBIT | -26.49% | -28.03% | -12.60% | 26.68% | 28.97% |
| EBITDA | -26.56% | -28.08% | -12.60% | 26.74% | 29.04% |
| EPS Basic | -32.71% | -28.95% | -8.25% | 34.40% | 38.15% |
| Normalized Basic EPS | -32.68% | -28.85% | -8.17% | 34.38% | 38.16% |
| EPS Diluted | -30.75% | -30.75% | -8.20% | 33.84% | 37.59% |
| Normalized Diluted EPS | -32.68% | -28.85% | -8.17% | 34.38% | 38.16% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |